Huntington Medical Research Institute

Pasadena, California 91105

0 studies enrolling now · 3 studies all time

What they study most

Hepatitis C, Non-alcoholic Steatohepatitis, Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis

Studies at this site

• A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus — Completed
• Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) — Completed
• Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders — Stopped early